Serum CA 125 concentrations in patients with benign ovarian tumours

This publication has 11 references indexed in Scilit:

• Sialyl-Tn, Sialyl-Lewis Xi, CA 19-9, CA 125, Carcinoembryonic Antigen, and Tissue Polypeptide Antigen in Differentiating Ovarian Cancer From Benign Tumors
  Obstetrics & Gynecology, 1992
• Tribute to Patrick Steptoe: beginnings of laparoscopy
  Human Reproduction, 1989
• Predictive value of preoperative serum CA 125 levels in clinically localized and advanced endometrial carcinoma
  American Journal of Obstetrics and Gynecology, 1988
• The distribution of CA 125 in the reproductive tract of pregnant and non‐pregnant women
  BJOG: An International Journal of Obstetrics and Gynaecology, 1988
• Explanation of the limited correlation between tumor CA 125 content and serum CA 125 antigen levels in patients with ovarian tumors
  Cancer, 1987
• The use of CA-125 in the diagnosis and management of endometriosis
  Fertility and Sterility, 1986
• Clinical Significance of Serum CA125 Values in Patients with Cancers of the Digestive System
  The Lancet Healthy Longevity, 1986
• Antigen detection by the monoclonal antibodies CA 19-9 and CA 125 in normal and tumor tissue and patients' sera
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1986
• A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer
  New England Journal of Medicine, 1983
• Tissue Distribution of a Coelomic- Epithelium-Related Antigen Recognized by the Monoclonal Antibody OC125
  International Journal of Gynecological Pathology, 1983